UK BIOBANK LIMITED
To provide a major genetic resource to assist scientists with research into a variety of diseases and illnesses.
Financial health, per its FY2025 accounts
The accounts state that free reserves increased to £7.9m, which is within the trustees' agreed policy target range of £5m to £10m. The charity reports a surplus for the year, driven by higher earned income from access fees and interest, while total income decreased by 10% due to the timing of grant recognition. The trustees confirm that sufficient funding is available to continue operations for the foreseeable future.
What the accounts disclose
“£270,001 to £280,000” — page 61
“Infrastructure Project Funding 24.9”
“the trustees consider an appropriate level of reserves to hold in respect of these risks is between £5m and £10m”
“The amount owing to the Charity by UKRI-MRC at the year-end was £11,570,000 (2024: £7,234,000) for unrestricted and restricted funding.” — page 74
“The amount owing to the University of Oxford at the year-end was £585,464 (2024: £nil) with accrued costs of £134,944 (2024: £85,186) and prepaid costs of nil (2024: £nil).” — page 74
“The amount owing to the Charity by UKRI-MRC at the year-end was £11,570,000 (2024: £7,234,000) for unrestricted and restricted funding.” — page 74
“The amount owing to the University of Oxford at the year-end was £585,464 (2024: £nil) with accrued costs of £134,944 (2024: £85,186) and prepaid costs of nil (2024: £nil).” — page 74
“The amount owing to the Charity by UKRI-MRC at the year-end was £11,570,000 (2024: £7,234,000) for unrestricted and restricted funding.” — page 74
“The amount owing to the University of Oxford at the year-end was £585,464 (2024: £nil) with accrued costs of £134,944 (2024: £85,186) and prepaid costs of nil (2024: £nil).” — page 74
“The amount owing to the Charity by UKRI-MRC at the year-end was £11,570,000 (2024: £7,234,000) for unrestricted and restricted funding.” — page 74
“The amount owing to the University of Oxford at the year-end was £585,464 (2024: £nil) with accrued costs of £134,944 (2024: £85,186) and prepaid costs of nil (2024: £nil).” — page 74
Corporate structure
- Registered company of the charity Companies House 04978912
Company officers (Companies House)
- WOOD, Anthony, Dr on trustee list
- WILLIAMS, Ceri Louise, Dr on trustee list
- MILLS, Melinda Catherine, Professor on trustee list
- TAYLOR, Bernard John on trustee list
- PERRIN, Nicola on trustee list
- FERGUSON, Michael Anthony John, Professor Sir on trustee list
- ROTHWELL, Nancy, Dame on trustee list
- KAKKAR, Ajay Kumar, Professor Lord on trustee list
- MARKHAM, Alexander Fred, Sir not on trustee list
- SELLORS, Jonathan Michael Holmes
Property (HM Land Registry)
Structured financials (annual return, FY ending 30/09/2025)
Trustees
- Lord Ajay Kumar Kakkarchair
- Bernard Taylor
- Dr Anthony Wood
- Dr Ceri Louise Williams
- Nicola Perrin
- PROFESSOR SIR ALEX MARKHAM
- Professor Dame Nancy Jane Rothwell
- Professor Melinda Catherine Mills
- Professor Sir Michael Ferguson
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 30/09/2025 | £68.9m | £47.3m |
| 30/09/2024 | £76.3m | £30.6m |
| 30/09/2023 | £34.5m | £32.1m |
| 30/09/2022 | £40.6m | £38.9m |
| 30/09/2021 | £62.7m | £63.6m |
Common questions
Is UK BIOBANK LIMITED financially healthy?
Per its FY2025 accounts: The accounts state that free reserves increased to £7.9m, which is within the trustees' agreed policy target range of £5m to £10m. The charity reports a surplus for the year, driven by higher earned income from access fees and interest, while total income decreased by 10% due to the timing of grant recognition. The trustees confirm that sufficient funding is available to continue operations for the foreseeable future. Its FY2025 accounts were audited by BDO LLP.
What does the highest-paid employee of UK BIOBANK LIMITED earn?
Per its FY2025 accounts, the highest-paid employee was in the £270,001 - £280,000 band.
Who funds UK BIOBANK LIMITED?
Funders whose own accounts filings name UK BIOBANK LIMITED as a grant recipient include WELLCOME TRUST.
Known funders
| Funder | Year | Amount | Purpose (as stated by the funder) |
|---|---|---|---|
| WELLCOME TRUST | FY2024 | £30.1m | Discovery Research |
Funders of similar charities
| Funder | Similar charities funded | Amount to them |
|---|---|---|
| THE BRITISH DIABETIC ASSOCIATION | 1 | £1.2m |
| BRITISH HEART FOUNDATION | 1 | £600k |
| Arthritis UK | 1 | £316k |
| Vivensa Foundation | 1 | £114k |
| THE HEALTH FOUNDATION | 1 | £100k |
| PROSTATE CANCER UK | 1 | £76k |
| THE JEAN SHANKS FOUNDATION | 1 | £25k |
| THE MICHAEL MARSH CHARITABLE TRUST | 1 | £4k |
Charities like this
- ASTHMA ALLERGY AND INFLAMMATION RESEARCH TRUST LIMITED
- BOURNEMOUTH AND POOLE HEALTHCARE TRUST (1)
- LABORATORY ANIMALS LIMITED
- THE SOCIETY OF CLINICAL PERFUSION SCIENTISTS OF GREAT BRITAIN AND IRELAND
- THE BRITISH URO-ONCOLOGY GROUP
- ACADEMY OF MEDICAL SCIENCES
Side by side with its peers
| Charity | Income | Top pay band | Staff >£60k | Reserves vs policy | Fundraising cost | Going concern |
|---|---|---|---|---|---|---|
| UK BIOBANK LIMITED | £68.9m | £270,001 - £280,000 | — | within | — | no doubt |
| ASTHMA ALLERGY AND INFLAMMATION RESEARCH TRUST LIMITED | £320k | — | 0 | unclear | — | no doubt |
| BOURNEMOUTH AND POOLE HEALTHCARE TRUST (1) | £4.4m | — | 0 | unclear | — | not going concern |
| LABORATORY ANIMALS LIMITED | £250k | — | 0 | unclear | — | no doubt |
| THE SOCIETY OF CLINICAL PERFUSION SCIENTISTS OF GREAT BRITAIN AND IRELAND | £283k | — | 0 | below | — | no doubt |
| THE BRITISH URO-ONCOLOGY GROUP | £231k | — | 0 | unclear | — | no doubt |